1 / 21

Motivational Interviewing & Severe & Persistent Mental Illness

Motivational Interviewing & Severe & Persistent Mental Illness. MINT Forum 2008 Susan Littrell, ML Ruef & Michael P. Giantini . Overview. Intent of the session

acacia
Download Presentation

Motivational Interviewing & Severe & Persistent Mental Illness

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Motivational Interviewing&Severe & Persistent Mental Illness MINT Forum 2008 Susan Littrell, ML Ruef & Michael P. Giantini

  2. Overview • Intent of the session • How does published information potentially influence MI training of persons working with clients having severe & persistent mental illness? • Potentially establish ongoing dialogue among interested MINTies • Current MI information in relation to SPMI • Themes • Discussion

  3. Effective therapist behaviors Rogers et.al. 1 • Study: The relationship of congruence, empathy & unconditional positive regard to ‘movement’ in therapy • Results: • “Schizophrenic clients” perceive low levels of these therapist behaviors and may increase slowly over time • “Schizophrenic clients” tend to perceive positive regard and congruence, i.e. relationship formation characteristics, more so than empathy, related to self-exploration

  4. Effective therapist behaviors • Unbiased raters and “schizophrenic clients” had similar evaluations of the three conditions • Therapist ratings of their own conditions were so discrepant, they were negatively associated • Some small improvement in client functional outcomes noted • Martino et al: MI (+) for cocaine & SPMI, Std. Psychiatric Interview (+) for marijuana & SPMI. MI effectiveness symptom related? 2

  5. Medication adherenceMcCracken & Corrigan 3 • Research literature (primarily Schizophrenia Spectrum Disorders): 3 • Combined educational, behavioral, affective, long-term interventions and positive alliance with providers along with concrete problem solving and motivational strategies 4 • Expect recurrence of adherence issues 5 • Compliance therapy (motivation related positive effect 6 , no effect 7)

  6. Medication adherence • Interview context: • Client with severe symptoms: • Primary focus – develop trusting relationship • Express empathy • Client stable with cognitive impairments: • Identify goals using a structured format of client’s life areas (e.g. living circumstances, social, money) • Prioritize goals & link to medication adherence • Use MI and costs/benefits

  7. Medication adherence • Recommendations: • Interview context influences how MI conducted • MI integrated into all components of treatment • Motivation continually assessed • Link medication adherence to client goals • Base MI interventions on type of resistance to change: • Rationalizing • Rebellious • Reluctant • Resigned

  8. Illness Management & Recovery 8 • Compilation of CBT research based interventions demonstrating improved outcomes in five areas: • Broad based psycho-education on mental illness • Medication focused programs (including adherence & shaping) • Relapse prevention (skills focused) • Coping skills training & comprehensive programs • CBT treatment for psychotic symptoms

  9. Illness Management & Recovery • Clinical consensus: • Motivational strategies critical and integral to all aspects of IMR delivery & outcomes • Ongoing need to link client goals to motivation towards specific skills • No specific research on MI to date • In public health domains – group format

  10. Integrated Dual Diagnosis Treatment 9 • Specific to severe & persistent mental illness • MI generally supported for decreased substance use 10 • Graeber et al controlled study - Positive 11 • Mixed results in individual sessions 12 • Majority of interventions delivered in group format

  11. Integrated Dual Diagnosis Treatment • Integral to treatment: • Functional assessments & analyses integral to treatment planning and skills development • Long term perspective • Staged interventions based on substance abuse treatment scale • Presupposes implementation within programs already delivering high quality psychiatric rehabilitation services (www.uspra.org)

  12. Co-occurring DisordersHandmaker, Packard & Conforti 13 • Transitioning IP to OP, treatment adherence & medication adherence • Staged match treatment services • Change: • talking about • tools for • practicing • maintaining • Need for skills development in addition to motivational considerations

  13. Dual Disorders & Treatment AdherenceZweben & Zuckoff 14 • Treatment adherence framework: • Improve problem acceptance: • Sources of non-adherence • Strategies • Improve treatment acceptance: • Sources of non-adherence • Strategies • Feedback

  14. Co-occurring DisordersMartino & Moyers 15 • Some MI modifications necessary due to • Multiple interacting behavioral targets • D & A, MH, medication and treatment adherence • Cognitive impairments • MI simplified, clarity and conciseness, successive reflections and summaries, concrete materials for eliciting change talk • Positive symptoms • Paraphrase to maintain reality-based and organized dialogue, use of metaphors and similes, caution regarding negative events/emotions, summarize ambivalence & quickly move to elicit change talk to resolve ambivalence

  15. Co-occurring DisordersMartino & Moyers • Negative symptoms • Paraphrase to stimulate discussion, time for client response, affirm participation, use of personalized & structured feedback • Non-MI interventions • Skill building and supportive interventions in addition to dual diagnosis issues, MI use or crisis interventions from ongoing assessment/monitoring of client symptoms • “It may be that MI makes its impact with dually diagnosed patients only when clinicians perform at the highest levels to accommodate the marked symptom & social impairments posed by psychotic illness.”

  16. Dialectical Behavioral TherapyLinehan 16 • Dialectical behavioral therapy conceptual framework: • Acceptance, reflective and validation approaches balanced with CBT skills development • Similar considerations for SPMI and co-occurring substance use • Similar clinical skill sets: • Therapist flexibility in providing both high quality validation and change strategies • Detailed description of treatment dynamics and balancing of acceptance, change & skills development

  17. Other areas • Physical health: • Persons with SPMI mortality rate 25 years below national average • Medical issues a major contributor • Criminal justice: • Jail diversion • Parole/probation involvement

  18. Themes • Relationship with provider essential • MI adaptations based on (psychotic) symptom severity • Recognition and support for long-term perspective • Client-centered versus MI • Simultaneous client goal and skill development identified via functional assessment & analysis • MI group skills • Possible need for high quality MI for effectiveness

  19. References 1. The Therapeutic Relationship & Its Impact: A Study of Psychotherapy with Schizophrenics, 1967, Ed. Carl R. Rogers, University of Wisconsin Press • Martino, S. et al., 2006, Addiction, 101, 1479-1492 • MI for Medication Adherence in Individuals with Schizophrenia, 2008, McCracken & Corrigan, in, MI in the Treatment of Psychological Problems, Eds. Arkowitz, Westra, Miller & Rollnick, Guilford Press • Dolder, C.R. et al., 2003, J. Clinical Psychopharmacology, 23, 389-399 • Zygmunt, A. et al., 2002, American Journal of Psychiatry, 159, 1653- 1664

  20. References • Kemp, R. et al., 1998, British Journal of Psychiatry, 172, 413-419. • O’Donnell, C. et al., 2003, British Medical Journal, 327, 834-837 • Mueser, K.T. et al., 2002, Psychiatric Services, 55 (10), 1272-1284 • Drake, RE et al., 2001, Psychiatric Services, 52, 469-476 • Drake, R.E. et al., 2004, Psychiatric Rehabilitation Journal, 27(4), 360-374 • Graeber, D.A. et al. 2003, Community Mental Health Journal, 39, 189-202

  21. References • Drake, R.E. et al., 2008, J. Substance Abuse Treatment, 34, 123-138 • Handmaker, N., Packard, M. & Conforti, K., 2002, MI in the Treatment of Dual Disorders, in, MI 2nd Edition, Miller & Rollnick, Guilford Press • Zweben, A. & Zuckoff, A., 2002, MI in the Treatment of Dual Disorders, in, MI 2nd Edition, Miller & Rollnick, Guilford Press • Martino, S. & Moyers, T.B. 2008, MI with Dually Diagnosed Patients in, MI in the Treatment of Psychological Problems, Eds. Arkowitz, Westra, Miller & Rollnick, Guilford Press • Linehan, M. M., CBT of Borderline Personality Disorder, 1993 Guilford Press

More Related